ClinConnect ClinConnect Logo
Search / Trial NCT01375530

Screening Volunteers for Clinical Trials

Launched by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) · Jun 16, 2011

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Prevention Vaccine Immunity Evaluate Screen

ClinConnect Summary

The Screening Volunteers for Clinical Trials study is looking for healthy individuals to help researchers learn more about vaccines and how they work. This study is part of a larger effort by the National Institute of Allergy and Infectious Diseases (NIAID) to find volunteers who may qualify for future vaccine trials. If you are between 18 and 60 years old and in good health, you may be eligible to participate.

As a volunteer, you will be asked questions about your health history and undergo a physical exam. Some blood and urine tests may be done to ensure you meet the health requirements for future studies. It's important to know that during this screening, you will not receive any investigational products or vaccines. If you’re interested in contributing to important vaccine research and meet the eligibility criteria, your participation could make a difference in understanding how to better protect people from diseases.

Gender

ALL

Eligibility criteria

  • * INCLUSION CRITERIA:
  • Age: 18 years of age or older
  • Able and willing to complete the informed consent process
  • Agree to have blood and/or tissue samples collected and stored for future studies of investigational products, the immune system, and/or other medical conditions
  • EXCLUSION CRITERIA:
  • A condition in which repeated blood draws or injections pose more than minimal risk for the subject such as hemophilia, other severe coagulation disorders or significantly impaired venous access
  • A condition that requires active medical intervention or monitoring to avert serious danger to the participant s health or well-being
  • Known to be pregnant or breast-feeding

About National Institute Of Allergy And Infectious Diseases (Niaid)

The National Institute of Allergy and Infectious Diseases (NIAID) is a key component of the National Institutes of Health (NIH) dedicated to advancing the understanding, prevention, and treatment of infectious and immune-mediated diseases. Through rigorous clinical trials, NIAID aims to foster innovative research that enhances public health and addresses global health challenges, including emerging infectious diseases and allergies. The institute collaborates with various partners, including academic institutions, industry, and international organizations, to translate scientific discoveries into effective therapies and vaccines. NIAID's commitment to high-quality clinical research is integral to improving health outcomes and informing policy decisions in the realm of infectious diseases and immunology.

Locations

Bethesda, Maryland, United States

Atlanta, Georgia, United States

Baltimore, Maryland, United States

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Lasonji A Holman, C.R.N.P.

Principal Investigator

National Institute of Allergy and Infectious Diseases (NIAID)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials